AI assistant
Sending…
Acumen Pharmaceuticals, Inc. — Director's Dealing 2021
Jul 9, 2021
34208_dirs_2021-07-08_f4b4a7c6-bbfe-48af-a8bd-a00e1c1035f5.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Acumen Pharmaceuticals, Inc. (ABOS)
CIK: 0001576885
Period of Report: 2021-07-06
Reporting Person: Fountain Nathan B (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-07-06 | Common Stock | P | 6250 | $16.00 | Acquired | 6250 | Direct |
More from Acumen Pharmaceuticals, Inc.
Declaration of Voting Results & Voting Rights Announcements
2026
Jun 3
Interim / Quarterly Report
2026
May 12
Report Publication Announcement
2026
May 12
Capital/Financing Update
2026
Apr 1
Capital/Financing Update
2026
Mar 26
Investor Presentation
2026
Mar 26
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Jan 28
Director's Dealing
2026
Jan 23
Director's Dealing
2026
Jan 23